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Summary 
Young MRL/MPJ-Ipr (1pr) mice 8-12 wk old challenged with alloantigen had significantly  lower 
specific cytolytic T  lymphocyte (CTL) responses  than control MRL/MPJ  +/+  mice.  Serum 
from lpr mice compared with serum from  + +  or normal C3H mice powerfully suppressed 
CTL responses in mixed lymphocyte cultures (MLC); absorbing lpr serum on protein G, adding 
antibody against transforming growth factor fl (TGF-fl) to cultures or dissociating immunoglobulin 
G (IgG) and TGF-fi before additions to cultures prevented suppression. Apparently autoantibody, 
similar to IgG produced by normal mice in response to immunization, carries  TGF-fl which 
suppresses  CTL responses  in vivo and in vitro. 
Ipr mice spontaneously develop autoimmunity  which is charac- 
terized by progressively severe splenomegaly, lymphadenop- 
athy, hypergammaglobulinemia, and immune deficiency, lpr 
mice carry a mutation of the FAS gene (1, 2). How the ab- 
sence of expression  of the normal FAS gene product, which 
is involved in one pathway causing apoptosis,  leads to au- 
toimmunity is not understood; nevertheless, Ipr mice are con- 
sidered a useful model for studying some aspects of autoim- 
munity, e.g.,  systemic  SLE,  that occur in humans (3-7). 
Normal mice immunized repeatedly with a single antigen 
develop high titers of specific antibody, and a small fraction 
of the specific IgG produced is associated with or carries TGF-fl 
which  suppresses  CD8 +  CTL responses  to  unrelated an- 
tigens (8, 9).  We report here that IgG autoantibodies pro- 
duced by lpr mice also have this property, and we suggest 
that such autoantibodies may play an important role in the 
pathogenesis of diseases caused by autoimmunity. 
Materials and Methods 
Mice, Sera, and Plasma.  MRL/MpJ-Ipr (lpr) and MRL/MpJ-+ 
(+ +) (H2  t) females 5-6 wk old were purchased from The Jackson 
Laboratory (Bar Harbor,  ME). BALB/c (H2  a)  and C3H/HeN 
mammary tumor virus-negative (H2  k) females were purchased 
from the Frederick Cancer Research Production Facility  (Frederick, 
MD). All mice were housed in the same barrier facility and fed 
sterile food and water. Most of the mice were small groups of three 
or four untreated, age-matched mice that became available to us 
at irregular intervals from another project. Anesthetized mice were 
exsanguinated  by heart puncture. Sera were tested on the same day. 
Aliquots were diluted 1:10 in RPMI-1640 and concentrated into 
>100-kD fractions by filtration/centrifugation  using Centricon 
microconcentrators  (Amicon, Beverly,  MA). The procedure reduced 
original volumes  by 1.5-3-fold, and samples were stored at -80~ 
until used. The original volumes of fractionated sera were restored 
before dilution; dilutions of sera recorded are final  concentrations 
in culture. Plasma was prepared from individual mice by diluting 
50/A of fresh blood obtained from the orbital plexus in 950/zl 
complete medium;  samples were centrifuged and  the  cell free 
supranatant was considered diluted 1:20. Sera were absorbed on 
protein G using HiTrapVMG (Pharmacia  LKB Biotechnology,  Upp- 
sala, Sweden). Sera were diluted in  a 0.1  M NaPO4 "binding 
buffer;" 1.0 ml aliquots was either untreated or added to columns 
(~2.0 min for additions and 10 min for absorption, the procedure 
repeated twice). Samples were diluted in complete media for testing 
in one-way MLC. Concentrations of IgG were determined in a 
modified ELISA assay  using goat anti-routine IgG (H + L) con- 
jugated to alkaline  phosphatase (Calbiochem-Novabiochem  Corp., 
La Jolla, CA). 
Immunizations.  Mice  under light anesthesia  were injected  in each 
hind foot pad with 0.05/il of a suspension of either sheep erythro- 
cytes (5%) or BALB/c spleen cells (2  x  108 cells/ml) suspended 
in RPMI-1640; injections were repeated every second day; mice 
were killed 4 and 6 d after the first injection for plaque forming 
cell (PFC) responses and 6 d after the first injection for CTL re- 
sponses. 
Cultures, Assays, and Reagents.  Cell preparations, media, cul- 
ture conditions, assays, and recording of data for CTL and PFC 
were the same as described in detail (8, 9). For most experiments 
each one-way MLC contained 5  x  108 normal C3H spleen cells 
as responders and 5  x  10  s irradiated (2,000 rad) BALB/c spleen 
cells as stimulators  in a final  volume of 200 #1. In experiments  com- 
paring spleen cells from Ipr mice with spleen cells from control 
mice as responders in one-way MLC, cultures were set up in 24- 
(macrocultures) as well as in 96-well plates (microcultures). Cell 
number and volume were 10-fold  higher in macrocultures. Mono- 
donal murine antibody against murine TGF-/32, -~3 was lot B2332 
from Genzyme Corp. (Cambridge, MA). 20/zl of antibody, 100 
#g/ml, was added per culture of responder and stimulator cells 
1 h before addition of murine serum to be tested. 
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Young Ipr Mice Have Usual Specific .antibody but Reduced 
Specific  CTL  Responses  on Immunization  with Exogenous An- 
tigens.  Six 1pr and six + +  mice 8-10 wk old were immunized 
in hind foot pads with SR.BC. Two mice in each group were 
killed at 4 d and the remaining four mice at 6 d. At 4 d virtu- 
ally  all  PFC  (>90%)  secreted  IgM:  9,000  and  11,000 
PFC/two lymph nodes from the two I  U  mice,  and 13,000 
and 14,000 PFC for lymph nodes from the two  + +  mice; 
all spleens  contained 2,000-4,000  PFC. By 6 d 80-90%  of 
PFC secreted IgG; responses for individual lpr mice were 9,000, 
52,000,  54,000,  and  109,000 PFC/two lymph  nodes,  and 
65,000, 72,000, 126,000,  and 152,000 PFC/two lymph nodes 
for + +  mice. Responses in spleens were low but comparable 
for the two groups.  Though not controlled within the ex- 
periment, the magnitude and variability of responses for both 
groups were comparable to responses we have  observed in 
many experiments using C3H mice immunized in the same 
way. 
In contrast to B cell responses, CTL responses stimulated 
by immunization with allogeneic spleen cells were approxi- 
mately  10-fold lower for lpr mice than  for  + +  mice.  For 
example, in one experiment four lpr mice and four + +  mice 
8 wks old were immunized  in foot pads with aUoantigen. 
The lymph node cells from each mouse were assayed separately 
in triplicate. Pools were also prepared from lymph nodes and 
from spleens. The pools were assayed in triplicate against the 
sensitizing  antigen,  P815 target cells (H 2k) and also against 
EL-4  target  cells  (H2  b)  for  nonspecific  lysis.  The  results 
recorded in Fig.  1 are for popliteal lymph node cells assayed 
separately and for pooled spleen cells. The magnitude of differ- 
ence between Ipr and  + +  lymph nodes was almost identical 
while comparing the means for individual mice or the means 
of responses for pooled lymph node cells.  All of the pools 
caused <10% lysis of EL-4 at E/T ratios of 100 or 50:1. The 
experiment was repeated using 17-wk-old mice with almost 
identical results except that  spleens of Ipr mice were larger 
(,,o3  x  10 s cells/spleen  compared  with  1.5  x  10  s cells/ 
spleen for younger Ipr mice). 
Response oflpr and + +  Spleen Cells in MLC.  Spleen cells 
from each of three lpr mice (two 10 wk and one 16 wk old), 
three  + +  mice (10, 16, and 21 wk old), and two C3H mice 
(10 and 16 wk old) were cultured separately in MLC. In mac- 
rocuhures, differences between CTL responses were less than 
twofold between any two of the eight mice;  the means of 
responses for the three Ipr mice at E/T ratios of 50:1,  12.5:1, 
and 3:1 were 84, 81, and 68% 51Cr release and for the three 
+ +  mice 85,  78,  and 59%  SlCr  release.  Since the spleens 
of Ipr mice were one and one half to two times larger than 
spleens of control mice, the numbers of reactive CTL must 
have been at least as high in spleens of Ipr as in  + +  mice. 
Interestingly, however, CTL responses were lower for Ipr mice 
than control mice when MLC were in microcuhures. Micro- 
cultures have one tenth the volume and cell number as mac- 
rocuhures, but cell density of sedimented cells in stationary 
cultures is approximately twofold lower because of the ratio 
of cell number to the area of the well bottom (107 cells/2.0 
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Figure  1.  Young lpr mice have lower CTL responses on sensitization 
with alloantigen  than control  + +  mice. (.4) Popliteal lymph nodes as- 
sayed individually  in triplicate;  (B) Spleens pooled and assayed in tripli- 
cate. Results  are the means for four mice per group  +  SD. 
cm  2 versus  106  cells/0.32  cm2).  Whereas  CTL  responses 
were almost identical in macro- and microcultures  for + +  and 
C3H mice, responses were approximately fourfold lower for 
Ipr cells in microcuhures, possibly because the enlarged spleens 
of lpr mice contain increased numbers of CD4-  CD8-  or 
other cells which are neutral or indifferent but interfere with 
specific cell-cell interactions required for generating specific 
CTL. We have not tested this possibility directly, but we have 
observed the same difference between responses in macro and 
microcuhure when comparing spleen cells from normal C3H 
mice and C3H mice with splenomegaly caused by immuno- 
genic tumors that have grown progressively for several weeks. 
Sera or Plasma from Ipr Mice Powerfully Suppresses CTL Re- 
sponses in MLC.  In four consecutive experiments, pools of 
fresh  sera were prepared  from groups,  three each,  of age- 
matched, untreated Iyr,  + +  mice and in two of the experi- 
ments pools from two C3H mice. Pools were tested on the 
same day in MLC.  None of the pools from  + +  or C3H 
mice caused suppression at a dilution of 1:800;  in contrast, 
all pools obtained from Ipr mice more than 6 wk old caused 
a greater than 4-10-fold suppression based on E/T ratios re- 
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In a fifth experiment,  fresh serum pooled from three 9-wk- 
old Ipr mice also caused  >10-fold  suppression  at a dilution 
of 1:800,  whereas  pooled sera from  age-matched  + +  and 
C3H mice caused no suppression  at this dilution  (data not 
presented). Aliquots of these three pools were fractionated/con- 
centrated and stored at  -80~  The three pools were tested 
again 3 mo later; Ipr serum was again approximately 10 times 
more suppressive than the control sera whether estimated by 
comparing the E/T ratio required to cause equivalent cytol- 
ysis or estimated by comparing dilutions  of serum causing 
equivalent  suppression  (Table 2). 
These results using pooled sera were confirmed in a sixth 
experiment using fresh plasma from four Ipr and four  + + 
9-wk-old mice and assayed individually.  The mean percent 
5tCr-release for 12  control cultures  with medium were 75, 
54,  and 26 at E/T ratios of 100:1,  25:1,  and 6.2:1.  All four 
plasma samples from lpr mice abolished  CTL  responses  at 
dilutions of 1:600 and 1:1800. All four plasma samples from 
+ +  mice caused  a less than  twofold  or no  suppression  at 
a  dilution  of 1:1800;  at  a dilution  of 1:600,  the lowest  re- 
sponse at E/T  ratios of 100:1,  25:1,  and  6.2:1  was 32,  27, 
and 7% and the mean responses for the group were 50, 34, 
and  10%  at  these  E/T  ratios. 
Suppression Caused by Ipr Serum Is Removed by Absorption 
on protein G or Is Prevented by Antibody to TGF-fl.  Aliquots 
of the same sera used in the experiment described in Table 
2 (fractionated/concentrated,  stored, and reconstituted) from 
9-wk-old mice were either untreated or absorbed on protein 
G.  The unbound  and  absorbed  samples were  then  diluted 
in culture medium and added to MLC. Untreated Ipr serum 
caused >4-fold suppression at a dilution of 1:1200,  data not 
shown, and >10-fold suppression at a dilution of 1:400. Ab- 
sorption of Ipr serum on protein G  greatly reduced suppres- 
sion caused by serum diluted  1:400 (Fig.  2 A).  The control 
serum absorbed on protein G had no effect on CTL responses. 
Aliquots of the same sera from 9-wk-old mice were used in 
a  separate experiment  for testing  the  effect of anti-TGF-/~ 
antibody on  suppression.  In the experiment  shown in Fig. 
2 B,  lpr serum diluted  1:600  or  1:1200  abolished  CTL re- 
sponses. The anti-TGF-/~ antibody at the concentration used 
increased responses suppressed by lpr serum diluted 1:600 by 
approximately fourfold (data not shown);  anti-TGF-B anti- 
body restored responses suppressed by Ipr serum diluted 1:1200 
(Fig.  2 B) and did not affect responses to control serum. In 
other experiments, murine IgG2a of unknown specificity used 
at the same concentration  as the  anti-TGF-~ had no effect 
on CTL responses  suppressed by immune sera.  The results 
reported in Fig.  2, A  and B were confirmed using different 
pooled lpr and  + +  sera (data not  shown). 
Dissociation of lgG and 7-GF-fl Eliminates Suppression Caused 
by lpr Serum.  IgG from murine  sera contains  1.0-10.0  ng 
Table  1.  Sera  from Ipr Mice Suppress CTL Responses in MLC 
Percent SlCr release 
E/T  ratio 
Exp  Medium or serum  Age of mice  50:1  12.5:1  3:1 
wk 
1  Medium control,  6 wk  -  94  +  10  61  -+  23  25  _+  10 
2  Medium control,  8 wk  -  84  _+  8  57  +_  13  23  _+  7 
3  Medium control,  11  wk  -  89  +  6  62  _+  8  24  +_  5 
4  Medium control,  17 wk  -  87  +_  5  73  _+  10  43  _+  14 
1  lpr  6  75  28  25 
2  lpr  8  48  19  8 
3  lpr  11  21  7  3 
4  lpr  17  53  17  3 
1  +  +  6  100  63  25 
2  +  +  8  96  59  22 
3  +  +  11  87  67  34 
4  +  +  17  91  67  30 
3  C3H  11  97  77  35 
4  C3H  17  100  87  39 
Results are for four consecutive experiments; each serum was a pool from three Ipr,  three  + +, or two C3H mice of the same age. All sera were 
diluted 1:800. The numbers recorded are means _+ SD for 10 or more replicate cultures for medium and for duplicate cultures for each pool of serum. 
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Percent  SlCr  release 
Serum  E/T  ratio 
Medium  or  serum  dilution  50:1  12.5:1  3:1 
Medium  -  87  _+  7  65  _+  1  33  _+  10 
lpr  1:300  22  _+  6  0  0 
1:900  7  •  5  0  0 
1:2700  44  •  31  24  _+  31  6  •  11 
+  +  1:300  57  •  24  27  _+  17  8  •  6 
1:900  89  •  8  72  •  13  31  _+  10 
1:2700  92  _+  5  71  •  7  28  •  4 
C3H  1:300  90  •  4  70  •  10  30  •  8 
1:900  87  •  6  70  •  5  28  •  7 
1:2700  81  •  4  63  •  5  22  •  3 
Sera were pools from three Ipr, three  +  +, and two C3H mice; results are for >100-kD fractions reconstituted to equal the volume before fractiona- 
tion.  The numbers recorded are means  _+  SD for  18 replicate cultures for medium and 3  replicate  cultures for each  serum dilution. 
Figure  2.  Suppression  of CTL responses in MLC caused 
by 1er serum is removed by protein G (A) and prevented by 
antibody (AB) to TGF/~ (B).  The results are the means  • 
SD for 10 replicate  control cultures for medium alone and 
for each of the variables  tested. 
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IgG, pH 2.0, for 30 min, cleaved active TGF-/3 from the la- 
tent form carried by IgG (9).  Acid-treated serum, though 
retaining full antibody activity and containing TGF-3 bio- 
logically active in a bioassay,  no longer suppressed CTL re- 
sponses in high dilution, presumably because IgG no longer 
focused through Fc receptors precise localization/activation 
of the latent TGF-3 carried by IgG (9). Similarly acidification 
of lpr serum greatly reduced the capacity of lpr sera to sup- 
press; for example in one experiment serum from lpr and + + 
mice were diluted 1:25  in normal saline;  one aliquot was 
acidified to pH 2.0 with 1.2 N  HC1 and neutralized with 
0.72 N NaOH 30 min later; the same quantities of acid and 
base were added simultaneously to control aliquots at the 
beginning of the procedure. At the end of 30 min the samples 
were diluted in medium and added to MLC. The means for 
SlCr release of 20 control cultures with only medium or sa- 
line were 90, 82, and 49% at E/T ratios of 50:1, 12.5:1, and 
3:1. Sera from  + +  mice, treated or untreated at a dilution 
of 1:400 had little or no effect on cultures. Sera from lpr mice 
treated simultaneously with acid and base abolished responses 
at a dilution of 1:400 (<10% SlCr release at all E/T ratios) 
and acidification for 30 min greatly reduced this suppression 
(70, 35, and 12% SlCr release at E/T ratios of 50:1, 12.5:1, 
and 3:1). 
Discussion 
Young 8-12-wk-old Ipr mice are in many ways comparable 
to normal mice immunized every 2 or 3 d for several weeks. 
The mice appear vigorous and healthy; spleens are enlarged 
but generalized lymphadenopathy is absent and total Ig levels 
are only slightly elevated (3, 4). Both lpr and repeatedly im- 
munized mice have usual antibody responses but reduced CTL 
responses to appropriate immunization.  High dilutions of 
sera or plasma from these mice suppress  CTL responses in 
culture, and removal of IgG by absorbing on protein G or 
adding antibody against TGF-/~ to cultures prevents suppres- 
sion. Furthermore, serum from either Ipr or immunized mice 
which has been treated by acidification to dissociate TGF-B 
from IgG no longer causes suppression. 
The  antigen  specificity of antibody obtained from im- 
munized normal mice is irrelevant for causing suppression 
of CTL responses. (We have tested immunizing with allogeneic 
cells from three mouse strains,  cells from three cell lines de- 
rived from different syngeneic immunogenic tumors, xeno- 
geneic erythrocytes from two species and TNP-KLH.) In fact, 
for selected experiments, we have purposely immunized normal 
mice with multiple antigens in order to boost the capacity 
of sera to suppress or to increase recovery of IgG-TGF-/3 from 
eluates or supranatants from cultured immunized cells. Au- 
toantibodies in lpr mice are apparently the product of poly- 
clonally stimulated B cells (10,  11) which have specificities 
for epitopes on ribonucleoproteins, histones, and DNA (12- 
15); the predominant isotype of these autoantibodies is IgG2a 
(16, 17). 2-3-mo-old/pr mice have only slightly elevated serum 
IgG levels and probably do not have circulating antigen- 
antibody complexes which appear later and cause complica- 
tions  such as nephritis in older ~r mice (6,  7). 
Collectively, the findings suggest that IgG autoantibodies, 
presumably of multiple specificities, and IgG antibodies pro- 
duced in response to specific immunization are comparable 
for suppressing CTL responses, and in both cases suppres- 
sion is mediated by TGF-/3 carried by IgG. Macrophages and 
functional Fc receptors are obligatory for IgG-TGF-B to cause 
suppression (9). We have recently demonstrated that isolated 
single B cells secrete IgG-TGF-/~ with TGF-/$ in the latent 
form and that antigen-antibody complexes are not required 
and may interfere with suppression (our manuscript in prep- 
aration). Presumably IgG as a binding protein for the secre- 
tion of latent TGF-~ focuses through Fc receptors the local 
activation of TGF-~ by macrophages. CD8 + CTL are essen- 
tial for effective host resistance to many, possibly all, viral 
infections (18-20). We proposed that IgG-TGF-~ produced 
in response to a growing tumor or some viral infections might 
promote escape of tumor or viral variants that are observed 
to emerge during tumor growth or infection (8). We now 
suggest that production of autoantibodies during the early 
stages of diseases such as SLE may suppress  the capacity of 
the individual to respond effectively to first or new viral in- 
fections. For this reason viral infections which are relatively 
innocuous for normal individuals may complicate the patho- 
genesis of autoimmunity. It is also conceivable that TGF-/3 
carried by IgG and focally activated where autoantibodies com- 
bine  with  autoantigens  may  stimulate  connective  tissue 
proliferation and scarring, characteristics of many autoim- 
mune diseases. 
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